JAMA Network Open· 2026Q1
Lifelong Genetic Inhibition of PCSK9 and Hepatic Safety
- 1citations
- Q1SCImago
- 2026year
Short summary
Rare loss-of-function variants in PCSK9 are associated with a reduced risk of liver-related outcomes, suggesting lifelong PCSK9 inhibition is safe for the liver.
AI-generated from the title and abstract; the full text is not read.
TakeawaysIn the app
Key pointsIn the app
Ask the paperIn the app
The rest is in the Pofolia app
Takeaways, key points and questions to the paper; new summaries every day for your field. Free.
Sign in on the web to openField: Surgery
SurgeryMedicine